Discover open access scientific publications

Search, annotate, share and cite publications

Publications by T. Jiang

Mechanistic Insights Into CED-4-mediated Activation of CED-3

Genes and Development

Genetics

Developmental Biology

2013

English

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy

English

MA09.11 Genomic Landscape and Its Correlation With TMB, CD8 TILs and PD-L1 Expression in Chinese Lung Squamous Cell Carcinoma

Journal of Thoracic Oncology

English

MA06.11 Distinct Origins of Lymphatic and Brain Metastasis in Lung Cancer

Journal of Thoracic Oncology

English

MA27.10 EGFR-Targeted Therapy Alters the Tumor Microenvironment in EGFR-Driven Lung Tumors: Rationale for Combination Therapies

Journal of Thoracic Oncology

English

P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

MA26.05 Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients With Different ALK Fusion-Variants

Journal of Thoracic Oncology

English

MA15.09 Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated With First-Line EGFR-TKIs

Journal of Thoracic Oncology

English

MA15.10 Loss of T790M Mutation Is Associated With Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

Journal of Thoracic Oncology

English

OA07.03 Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC PTS With Oligometastatic or Oligoprogressive Liver Metastases

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by T. Jiang

Mechanistic Insights Into CED-4-mediated Activation of CED-3

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy

MA09.11 Genomic Landscape and Its Correlation With TMB, CD8 TILs and PD-L1 Expression in Chinese Lung Squamous Cell Carcinoma

MA06.11 Distinct Origins of Lymphatic and Brain Metastasis in Lung Cancer

MA27.10 EGFR-Targeted Therapy Alters the Tumor Microenvironment in EGFR-Driven Lung Tumors: Rationale for Combination Therapies

P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer

MA26.05 Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients With Different ALK Fusion-Variants

MA15.09 Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated With First-Line EGFR-TKIs

MA15.10 Loss of T790M Mutation Is Associated With Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

OA07.03 Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC PTS With Oligometastatic or Oligoprogressive Liver Metastases